MrMed Achieves Record Growth with 50% Revenue Surge in FY24!

MrMed, India's leading online platform for speciality medicines, announced its remarkable financial achievements for the fiscal year 2024 (FY24). These achievements underscore the company's commitment to making healthcare more accessible and affordable across the country. The company successfully reduced its overall losses by 31%, bringing them down to ₹1.5 crore, a significant improvement from the previous fiscal year.

The company reported a 50% increase in revenue, reaching ₹24 crores for FY24, reflecting the growing demand for affordable speciality medicines and its ability to cater to patients effectively across India. Additionally, MrMed recorded a 177% increase in gross margins, demonstrating its focus on operational efficiency and an enhanced product portfolio. The company also achieved a 50% reduction in the percentage of losses, showcasing its strategic approach to cost optimisation and driving profitability.

Devashish Singh, Co-Founder and CEO of MrMed, expressed his gratitude for the company's exceptional growth, stating, "We owe our success to the unwavering trust and support of our advocates, who go beyond being just customers. Their confidence in us and their word-of-mouth recommendations have allowed us to grow organically without relying heavily on marketing.

Every milestone we achieve is a testament to our dedication to our patients and caregivers. We ensure timely access to life-saving medications for those battling serious conditions like cancer, chronic diseases, and infections such as HIV and hepatitis. Our growth isn't merely about financial success-it's about creating a meaningful impact in people's lives, which fuels our passion and commitment every day.

MrMed's financial progress aligns seamlessly with its mission to make life-saving and speciality medicines more accessible and affordable. The company's operational excellence and strategic efforts have not only improved profitability but also reinforced its position as a trusted partner for patients in need. Founded in 2021, MrMed has consistently worked to dispel the stigma surrounding the high cost of speciality medicines by ensuring timely access to affordable and genuine medications for patients across India.

With a strong focus on technology, MrMed ensures seamless delivery of life-saving medicines even to remote corners of the country. Its investment in cold-chain infrastructure and robust quality checks guarantees that medicines arrive in pristine condition, further enhancing patient trust. The company's organic growth reflects its ability to resonate deeply with the healthcare community, including caregivers, patients, and medical professionals.

Company: MrMed.in
Website: https://www.mrmed.in/
Address: No. 5 (3), Ground Floor, Raja Street, T-Nagar, Chennai - 600017 (India)
Phone: +91-8939169999
Email: support@mrmed.in

MrMed is a leading online pharmacy in India, specializing in providing super-speciality medicines for critical conditions like cancer, kidney diseases, HIV/AIDS, arthritis, transplants, hepatitis, and more. MrMed's mission is to create a transparent, trustworthy and efficient healthcare ecosystem using technology that makes patient care more accessible and affordable.

This release was published on openPR.